Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Clinical trial NCT01483144 · COMPLETED
Trial details
- NCT number
- NCT01483144
- Sponsor
- Cancer Prevention Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2018-11-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.